54 research outputs found
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort.
Randomized trials and observational cohorts reported higher rates of virological suppression after highly active antiretroviral therapy
(HAART) including efavirenz (EFV), compared with boosted protease inhibitors (PIs). Correlations with immunological and clinical
outcomes are unclear. Patients of the Italian MASTER cohort who started HAART from 2000 to 2010 were selected. Outstanding
outcome (composite outcome for success (COS)) was introduced. We evaluated predictors of COS (no AIDS plus CD4+ count >500/
mm3 plus HIV-RNA <500 copies/mL) and of eight single outcomes either at month 6 or at year 3. Multivariable logistic regression was
conducted. There were 6259 patients selected. Patients on EFV (43%) were younger, had greater CD4+ count, presented with AIDS less
frequently, and more were Italians. At year 3, 90% of patients had HIV RNA <500 copies/mL, but only 41.4% were prescribed EFV, vs.
34.1% prescribed boosted PIs achieved COS (p <0.0001). At multivariable analysis, patients on lopinavir/ritonavir had an odds ratio of
0.70 for COS at year 3 (p <0.0001). Foreign origin and positive hepatitis C virus-Ab were independently associated with worse outcome
(OR 0.54, p <0.0001 and OR 0.70, p 0.01, respectively). Patients on boosted PIs developed AIDS more frequently either at month 6
(13.8% vs. 7.6%, p <0.0001) or at year 3 (17.1% vs. 13.8%, p <0.0001). At year 3, deaths of patients starting EFV were 3%, vs. 5% on
boosted PIs (p 0.008). In this study, naïve patients on EFV performed better than those on boosted PIs after adjustment for imbalances at
baseline. Even when virological control is achieved, COS is relatively rare. Hepatitis C virus-positive patients and those of foreign origin
are at risk of not obtaining COS.
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All
rights reserved
Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART
Immunological non-response (INR) despite virological suppression is associated with AIDS-defining events/death (ADE). Little is known about its association with serious non-AIDS-defining events (nADE)
Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey
Background: The aim was to establish how patients experience the impact of spondyloarthritis (SpA) on work disability
and working life. Methods: The survey was performed in 17/20 regions in Italy (1 January to 31 March 2013). A multiple-choice
questionnaire was published on the official website of the sponsor - the National Association of Rheumatic Patients
(ANMAR) - and hard-copies were distributed at outpatient clinics for rheumatic patients.
Results: Respondents (n = 770) were of both sexes (56 % men), educated (62 % at high school or more), of working
age (75 % aged 6460 years), and affected by SpA. The most common types diagnosed were ankylosing spondylitis (AS)
(39 %) and psoriatic arthritis (PsA) (36 %). Respondents were working full-time (45 %), part-time (8 %) or had retired (22 %);
15 % were unemployed (for reasons linked to the disease or for other reasons, students or housewives). Patients reported
disability (39 %), were receiving disability benefits (34 %), were experiencing important limitations that were hindering
their professional development/career (36 %) and some had to change/leave their job or lost it because of SpA (21 %).
Employed respondents (n = 383) had worked on average 32.2 h in the last 7 days. More hours of work were lost over the
last 7 days due to SpA (2.39 h vs 1.67 h). The indirect costs of the disease amounted to \u20ac106/week for patients reporting
well-being/good physical conditions/improvement and \u20ac216/week for those reporting permanent impairment.
Conclusions: Most patients were in the midst of their productive years and were experiencing considerable difficulties in
carrying out their job because of the disease: half of them reported disability and one third were experiencing important
limitations in their career perspective
Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey
Background: The aim was to establish how patients experience the impact of spondyloarthritis (SpA) on work disability
and working life. Methods: The survey was performed in 17/20 regions in Italy (1 January to 31 March 2013). A multiple-choice
questionnaire was published on the official website of the sponsor - the National Association of Rheumatic Patients
(ANMAR) - and hard-copies were distributed at outpatient clinics for rheumatic patients.
Results: Respondents (n = 770) were of both sexes (56 % men), educated (62 % at high school or more), of working
age (75 % aged ≤60 years), and affected by SpA. The most common types diagnosed were ankylosing spondylitis (AS)
(39 %) and psoriatic arthritis (PsA) (36 %). Respondents were working full-time (45 %), part-time (8 %) or had retired (22 %);
15 % were unemployed (for reasons linked to the disease or for other reasons, students or housewives). Patients reported
disability (39 %), were receiving disability benefits (34 %), were experiencing important limitations that were hindering
their professional development/career (36 %) and some had to change/leave their job or lost it because of SpA (21 %).
Employed respondents (n = 383) had worked on average 32.2 h in the last 7 days. More hours of work were lost over the
last 7 days due to SpA (2.39 h vs 1.67 h). The indirect costs of the disease amounted to €106/week for patients reporting
well-being/good physical conditions/improvement and €216/week for those reporting permanent impairment.
Conclusions: Most patients were in the midst of their productive years and were experiencing considerable difficulties in
carrying out their job because of the disease: half of them reported disability and one third were experiencing important
limitations in their career perspective
OCULAR MANIFESTATIONS IN HIV-SEROPOSITIVE PATIENTS
A total of 153 patients with human immunodeficiency virus (HIV) infection underwent complete ophthalmologic examinations for the presence of any eye pathology. We wanted to show a correlation between such pathology and total CD4+ lymphocyte count, believed to be an indicator of immunologic status. The most frequently encountered lesions were cotton-wool patches, vascular congestion, hemorrhages, chorioretinitis, segmental vasculitis, and pallid papilla. Almost all of the patients with ocular anomalies also had a CD4+ count of less than 200 cells/mm3 suggesting that ocular lesions have a negative prognostic significance even in asymptomatic patients who present with a severe impairment of their immune system
Utilità del dosaggio della neopterina e della P24 per la stadiazione dell' infezione da HIV
Long-term administration of Inosine-Pranobex (INPX) in anti-HIV asymptomatic carriers. Preliminary results of a controlled study
- …